S. Mesrine

发表

A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort

Stefan Michiels, Laura Baglietto, Guy Fagherazzi, 2015, Breast Cancer Research and Treatment.

Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)

U. Ekelund, E. Riboli, P. Vineis, 2015, BDJ.

Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study.

F. Clavel-Chapelon, A. Fournier, M. Gunter, 2019, The American journal of clinical nutrition.

Risk factors for onset of menopausal symptoms: results from a large cohort study.

F. Clavel-Chapelon, A. Fournier, S. Sabia, 2008, Maturitas.

Risk of onset of menopausal symptoms in periods surrounding menopause.

F. Clavel-Chapelon, A. Fournier, S. Sabia, 2007, Maturitas.

Alcohol consumption and breast cancer risk subtypes in the E3N-EPIC cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

C. Friedenreich, F. Clavel-Chapelon, F. Berrino, 2007, The Journal of clinical endocrinology and metabolism.

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

I. Gram, F. Clavel-Chapelon, A. Fournier, 2016, PloS one.

Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

I. Gram, F. Clavel-Chapelon, A. Fournier, 2016, PloS one.

Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort

F. Clavel-Chapelon, A. Fournier, M. Duclos, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

V. Beral, Jane Green, R. Collins, 2019, The Lancet.

Author's Response On the roles of skin type and sun exposure in the risk of endometriosis and melanoma

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2011 .

Chronic pain and risk of falls in older adults.

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, JAMA.

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

F. Clavel-Chapelon, I. Romieu, A. Jiménez-Corona, 2014, Cancer Causes & Control.

Serum 25(OH) Vitamin D and Risk of Breast Cancer: A Nested Case-Control Study from the French E3N Cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Prediagnostic body size and breast cancer survival in the E3N cohort study

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2016, International journal of cancer.

Physical activity, sex steroid, and growth factor concentrations in pre- and post-menopausal women: a cross-sectional study within the EPIC cohort

C. Friedenreich, A. Fournier, E. Riboli, 2013, Cancer Causes & Control.

Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition

C. Friedenreich, F. Clavel-Chapelon, E. Riboli, 2007, Cancer Causes & Control.

Vitamin C supplement intake and postmenopausal breast cancer risk: interaction with dietary vitamin C.

F. Clavel-Chapelon, A. Fournier, C. Cadeau, 2016, The American journal of clinical nutrition.

Hip circumference is associated with the risk of premenopausal ER−/PR− breast cancer

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2012, International Journal of Obesity.

Anthropometric features and cutaneous melanoma risk: a prospective cohort study in French women.

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2014, Cancer epidemiology.

E3N ATVB R2 1/25 Title: Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: Results from the E3N cohort study Short title: Hormone therapy and venous thromboembolism

Marianne, F. Clavel-Chapelon, E. Oger, 2015 .

Risk of asthma onset after natural and surgical menopause: Results from the French E3N cohort.

A. Fournier, G. Severi, B. Leynaert, 2018, Maturitas.

Postmenopausal hormone therapy and asthma onset in the E3N cohort

F. Clavel-Chapelon, A. Fournier, I. Romieu, 2010, Thorax.

Life course evolution of body size and breast cancer survival in the E3N cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2018, International journal of cancer.

Body‐size throughout life and risk of depression in postmenopausal women: Findings from the E3N cohort

F. Clavel-Chapelon, S. Mesrine, G. Fagherazzi, 2014, Obesity.

Lifetime endogenous reproductive factors and severe depressive symptoms in postmenopausal women: findings from the E3N cohort

F. Clavel-Chapelon, M. Ancelin, S. Mesrine, 2013, Menopause.

Risks of colon and rectal adenomas are differentially associated with anthropometry throughout life: the French E3N prospective cohort.

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2011, International journal of epidemiology.

Association between Five Lifestyle Habits and Cancer Risk: Results from the E3N Cohort

F. Clavel-Chapelon, L. Dartois, S. Mesrine, 2014, Cancer Prevention Research.

Anthropometric factors in adulthood and risk of colorectal adenomas: The French E3N-EPIC prospective cohort.

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, American journal of epidemiology.

Height, Sitting Height, and Leg Length in Relation with Breast Cancer Risk in the E3N Cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2013, Canadian Medical Association Journal.

[Characteristics and determinants of initiation of premenopausal use of oral progestagens in the French E3N cohort].

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2010, Journal de gynecologie, obstetrique et biologie de la reproduction.

Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

J. Chang-Claude, F. Clavel-Chapelon, E. Riboli, 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort

F. Clavel-Chapelon, A. Fournier, C. Cadeau, 2016, International journal of cancer.

Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l ’ Education Nationale ( E 3 N ) cohort

F. Clavel-Chapelon, A. Fournier, B. Balkau, 2011 .

Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort

F. Clavel-Chapelon, A. Fournier, B. Balkau, 2009, Diabetologia.

MENOPAUSAL HORMONE THERAPY AND NEW-ONSET DIABETES IN THE FRENCH E 3 N COHORT

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2009 .

Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.

F. Clavel-Chapelon, A. Fournier, C. Cadeau, 2015, The American journal of clinical nutrition.

Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.

F. Clavel-Chapelon, A. Fournier, L. Baglietto, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC) 1–6

U. Ekelund, E. Riboli, P. Vineis, 2015 .

Nevi, Ambient Ultraviolet Radiation, and Thyroid Cancer Risk: A French Prospective Study

F. Clavel-Chapelon, L. Wald, S. Mesrine, 2017, Epidemiology.

Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case‐control study in nonsmoking postmenopausal women from the EPIC cohort

E. Riboli, E. Weiderpass, N. Wareham, 2016, International journal of cancer.

Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years

F. Clavel-Chapelon, A. Fournier, G. Gusto, 2018, European Journal of Clinical Pharmacology.

Postmenopausal hormone therapy and asthma onset in the E 3 N cohort Running Title : Hormone therapy and asthma

A. Fournier, I. Romieu, B. Leynaert, 2019 .

Pigmentary traits and risk of endometriosis.

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, Human reproduction.

Meat Consumption and Health Outcomes

F. Pierre, S. Mesrine, M. Boutron‐Ruault, 2017 .

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Heather Eliassen, Karen Canfell, Julian Peto, 2012, The Lancet. Oncology.

Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years

F. Clavel-Chapelon, A. Fournier, G. Gusto, 2018, European Journal of Clinical Pharmacology.

Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2012, European Journal of Epidemiology.

Determinants of age at menarche and time to menstrual cycle regularity in the French E3N cohort.

F. Clavel-Chapelon, B. Fervers, S. Mesrine, 2012, Annals of epidemiology.

Latitude and ultraviolet radiation dose in the birthplace in relation to menarcheal age in a large cohort of French women.

F. Clavel-Chapelon, J. Verdebout, B. Fervers, 2013, International journal of epidemiology.

Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N‐EPIC cohort

F. Clavel-Chapelon, L. Baglietto, L. Dartois, 2016, International journal of cancer.

Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study

A. Fournier, E. Riboli, S. Franceschi, 2015, International journal of cancer.

Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women.

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2007, Archives of internal medicine.

Associations among body size across the life course, adult height and endometriosis

F. Clavel-Chapelon, S. Missmer, G. Gusto, 2017, Human reproduction.

Childhood and Adolescent Exposures and the Risk of Endometriosis

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2013, Epidemiology.

Measured Adiposity in Relation to Head and Neck Cancer Risk in the European Prospective Investigation into Cancer and Nutrition

E. Riboli, P. Vineis, A. Tjønneland, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis.

J. Chang-Claude, F. Clavel-Chapelon, E. Riboli, 2013, American journal of epidemiology.

Oral progestagens before menopause and breast cancer risk

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2007, British Journal of Cancer.

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

F. Clavel-Chapelon, I. Romieu, A. Jiménez-Corona, 2014, Cancer Causes & Control.

Erratum: The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: Results from the EPIC cohort (PLoS ONE (2016) 11:1 (e0147029) DOI:10.1371/journal.pone.0147029)

F. Clavel-Chapelon, A. Fournier, E. Riboli, 2016 .

Title: Measured adiposity in relation to head and neck cancer risk in the European Prospective Investigation into Cancer and Nutrition

E. Riboli, P. Vineis, A. Tjønneland, 2017 .

Height, age at menarche and risk of hormone receptor‐positive and ‐negative breast cancer: A cohort study

V. McCormack, I. Gram, E. Riboli, 2013, International journal of cancer.

Endometriosis and the risk of skin cancer: a prospective cohort study

S. Missmer, L. Dartois, S. Mesrine, 2017, Cancer Causes & Control.

Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor–Positive and -Negative Breast Cancer: a Nested Case–Control Study

R. E. James, J. Chang-Claude, F. Clavel-Chapelon, 2011, Cancer Prevention Research.

Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort.

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2009, International journal of epidemiology.

Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study

F. Clavel-Chapelon, L. Dartois, S. Mesrine, 2016, Cancer Causes & Control.

Association between Melanocytic Nevi and Risk of Breast Diseases: The French E3N Prospective Cohort

Laura Baglietto, Françoise Clavel-Chapelon, Laure Dossus, 2014, PLoS medicine.

Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.

F. Clavel-Chapelon, E. Riboli, P. Vineis, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

I. Gram, E. Riboli, A. Tjønneland, 2016, Clinical Cancer Research.

Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Unsuspected Consequences of the Adolescent Overweight Epidemic

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2007, Pediatrics.

Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2014, American journal of epidemiology.

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

F. Clavel-Chapelon, A. Fournier, F. Berrino, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weight change in middle adulthood and breast cancer risk in the EPIC‐PANACEA study

J. Chang-Claude, F. Clavel-Chapelon, E. Riboli, 2014, International journal of cancer.

Insulin-like Growth Factor-I and Risk of Differentiated Thyroid Carcinoma in the European Prospective Investigation into Cancer and Nutrition

E. Riboli, S. Franceschi, A. Tjønneland, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism: Results From the E3N Cohort Study

F. Clavel-Chapelon, A. Fournier, E. Oger, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Postmenopausal Hormone Therapy and Risk of Idiopathic Venous Thromboembolism Results From the E 3 N Cohort Study

F. Clavel-Chapelon, A. Fournier, E. Oger, 2009 .

Physical activity and risk of endometrial cancer: The European prospective investigation into cancer and nutrition

C. Friedenreich, F. Clavel-Chapelon, E. Riboli, 2007, International journal of cancer.

Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)

U. Ekelund, A. Fournier, E. Riboli, 2015, BDJ.

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort

F. Clavel-Chapelon, A. Fournier, S. Mesrine, 2014, Breast Cancer Research and Treatment.

Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study.

M. Plummer, I. Gram, F. Clavel-Chapelon, 2011, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cutaneous melanoma and endogenous hormonal factors: a large French prospective study.

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2011, American journal of epidemiology.

Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study

F. Clavel-Chapelon, E. Riboli, A. Tjønneland, 2015, British Journal of Cancer.

Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition

E. Riboli, A. Tjønneland, K. Overvad, 2022 .

Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study

F. Clavel-Chapelon, E. Riboli, S. Franceschi, 2016, International journal of cancer.

Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.

Françoise Clavel-Chapelon, F. Clavel-Chapelon, A. Fournier, 2011, American journal of epidemiology.

Joint Effects of Dietary Vitamin D and Sun Exposure on Breast Cancer Risk: Results from the French E3N Cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Endometriosis and the risk of skin cancer: a prospective cohort study

S. Missmer, L. Dartois, S. Mesrine, 2017, Cancer Causes & Control.

Physical activity, sex steroid, and growth factor concentrations in pre- and post-menopausal women: a cross-sectional study within the EPIC cohort

C. Friedenreich, A. Fournier, E. Riboli, 2013, Cancer Causes & Control.

Progestagens Use Before Menopause and Breast Cancer Risk According to Histology and Hormone Receptors

F. Clavel-Chapelon, A. Fournier, F. Berrino, 2008, Cancer Epidemiology Biomarkers & Prevention.

Relation between hysterectomy, oophorectomy and the risk of incident differentiated thyroid cancer: The E3N cohort

F. Clavel-Chapelon, F. Bonnet, L. Dartois, 2018, Clinical endocrinology.

Physical Activity and all-cause mortality across levels of general and abdominal adiposity: The European Prospective Investigation into Cancer and Nutrition Study (EPIC)

U. Ekelund, A. Fournier, E. Riboli, 2015 .

Association between Five Lifestyle Habits and Cancer Risk: Results from the E3N Cohort

F. Clavel-Chapelon, L. Dartois, S. Mesrine, 2014, Cancer Prevention Research.

Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis.

J. Chang-Claude, F. Clavel-Chapelon, A. Tjønneland, 2013, American journal of epidemiology.

Joint Effects of Dietary Vitamin D and Sun Exposure on Breast Cancer Risk: Results from the French E3N Cohort

F. Clavel-Chapelon, S. Mesrine, M. Boutron‐Ruault, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study

F. Clavel-Chapelon, S. Franceschi, A. Tjønneland, 2016, International Journal of Cancer.

American Journal of Epidemiology Original Contribution Anthropometric Factors in Adulthood and Risk of Colorectal Adenomas the French E3n-epic Prospective Cohort

S. Mesrine, M. Boutron‐Ruault, Marine Josset, 2022 .

American Journal of Epidemiology Original Contribution Risk of Osteoporotic Fractures after Discontinuation of Menopausal Hormone Therapy: Results from the E3n Cohort

S. Mesrine, M. Boutron‐Ruault, P. Engel, 2022 .

Vitamin C supplement intake and postmenopausal breast cancer risk: interaction with dietary vitamin C.

F. Clavel-Chapelon, A. Fournier, C. Cadeau, 2016, The American journal of clinical nutrition.

Progestagens Use Before Menopause and Breast Cancer Risk According to Histology and Hormone Receptors

F. Clavel-Chapelon, A. Fournier, F. Berrino, 2008, Cancer Epidemiology Biomarkers & Prevention.